Award
National Heart, Lung, and Blood Institute 5R01HL169631-03
Managing Alpha-1-Antitrypsin Deficiency (AATD) through Proteostasis Signaling Pathways
Recipient
William Edward Balch
Award Amount
$855,694.00
Ceiling
$855,694.00
Awarded
February 27, 2026
Identifier
5R01HL169631-03
NIH grant awarded by NHLBI for research on therapeutic approaches to Alpha-1-antitrypsin deficiency using proteostasis signaling pathways, with an award amount of $855,694.
Description
This is a NIH grant project focused on developing therapeutic approaches for Alpha-1-antitrypsin deficiency through manipulation of proteostasis signaling pathways, involving small molecule activators and Gaussian process machine learning tools. The project is funded by NHLBI with a total award amount of $855,694 for fiscal year 2026.